Epithalon

What it is

Epithalon is a four-amino-acid synthetic peptide developed in Russia from research into pineal gland extracts. It is associated with telomerase activity in animal studies — telomerase is the enzyme that maintains the protective caps on chromosomes.

Honest summary: the Russian research is real but has not been independently replicated at scale. Whether it does what its promoters claim in humans is unproven.

History

Developed by Vladimir Khavinson in Russia from the 1980s onwards. Long-term Russian studies date back over 30 years.

How it works

Hypothesised to upregulate telomerase, modulate the pineal gland, and improve sleep and circadian rhythm regulation.

Dosage

• 5–10 mg daily for 10–20 days, repeated 2–4 times per year.
• Some protocols use lower daily doses spread over longer periods.

How it is taken

• Subcutaneous injection.

How to reconstitute

• 50 mg vial with 5 ml BAC water = 10 mg/ml. 10 mg = 100 units on a 1 ml insulin syringe.

How it should arrive

White powder, sealed vial.

How it should look once reconstituted

Clear colourless solution.

What to expect, and when

• Sleep / energy improvements reported by some users in 1–2 weeks.
• Longevity-style outcomes are obviously not assessable in any practical timeframe.

Side effects

• Generally well tolerated.
• Occasional mild fatigue.

Risks

• Limited replication of long-term Russian results in Western research.
• Theoretical: any telomerase-activating agent has a hypothetical cancer-promotion concern.

Potential gains

• Some users report improved sleep and circadian regulation.
• Longevity claims are extrapolated from animal data and small Russian studies.

Other useful information

One of the peptides where the marketing is significantly out ahead of the evidence. Reasonable to experiment with given the safety profile, but treat the longevity claims with caution.